![Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy | Alzheimer's Research & Therapy | Full Text Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy | Alzheimer's Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Falzrt160/MediaObjects/13195_2012_Article_134_Fig1_HTML.jpg)
Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy | Alzheimer's Research & Therapy | Full Text
![The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias | Semantic Scholar The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/713fb7cafbb2fe25adb48f5d13c4df3e06157080/5-TableII-1.png)
The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias | Semantic Scholar
![PDF) Memantine and Acetylcholinesterase Inhibitor Treatment in Cases of CDR 0.5 or Questionable Impairment PDF) Memantine and Acetylcholinesterase Inhibitor Treatment in Cases of CDR 0.5 or Questionable Impairment](https://i1.rgstatic.net/publication/24191718_Memantine_and_Acetylcholinesterase_Inhibitor_Treatment_in_Cases_of_CDR_05_or_Questionable_Impairment/links/54f5f0d70cf2ca5efefd73b9/largepreview.png)
PDF) Memantine and Acetylcholinesterase Inhibitor Treatment in Cases of CDR 0.5 or Questionable Impairment
The Therapeutic effect of Memantine through the Stimulation of Synapse Formation and Dendritic Spine Maturation in Autism and Fragile X Syndrome
![Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor Antagonists | SpringerLink Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor Antagonists | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40263-020-00789-3/MediaObjects/40263_2020_789_Fig1_HTML.png)
Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor Antagonists | SpringerLink
![PDF] High-Dose Donepezil or Memantine: Next Step for Alzheimer's Disease? Larger Dosages May Benefit Patients Who Have 'Maxed Out' Existing Therapies | Semantic Scholar PDF] High-Dose Donepezil or Memantine: Next Step for Alzheimer's Disease? Larger Dosages May Benefit Patients Who Have 'Maxed Out' Existing Therapies | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b15d42c0bd4815bdf03544d13e163934bf0646c5/2-Table1-1.png)